Next-Gen Drug Significantly Prevents Return of and Death From Endometrial Cancer
October 26, 2026
October 26, 2026
NEW YORK, Oct. 26 [Category: BizHospital] -- NYU Langone Health, an academic medical center affiliated with New York University, posted the following news release:
* * *
Next-Gen Drug Significantly Prevents Return of and Death From Endometrial Cancer
*
A new drug is effective at decreasing recurrence of and death from endometrial cancer, a landmark international study shows.
The drug, called sacituzumab tirumotecan (sac-TMT), attac . . .
* * *
Next-Gen Drug Significantly Prevents Return of and Death From Endometrial Cancer
*
A new drug is effective at decreasing recurrence of and death from endometrial cancer, a landmark international study shows.
The drug, called sacituzumab tirumotecan (sac-TMT), attac . . .